Analysis of Clinico-Pathological Factors Which Influence the Expression of Estrogen Receptor in Breast Carcinoma

HAO Jing,WANG Xiu-mei,YI Cui-hua,YU Xue-jun,ZHANG Xin,HU Dong-yan,LI Ming,YU Jin-ming
DOI: https://doi.org/10.3969/j.issn.1009-9905.2006.04.015
2006-01-01
Abstract:Objective:To investigate the clinicopathological parameters which influence the expression of estrogen receptor(ER)in breast carcinomas.Methods:The expression of ER together with progesterone receptor(PR),Ki67,C-erbB-2 and hypoxia inducible factor-1α (HIF-1α)were assessed by immunohistochemistry in 76 cases of breast carcinoma,and their correlation with the other clinicopathological factors were also analyzed.Results:ER,Ki67,C-erbB-2 and HIF-1α staining were observed in 67.1%,39.5%,31.6% and 54.0% respectively.ER status was inversely correlated with expression of Ki67,C-erbB-2 and HIF-1α.Besides,ER status had a positive correlation with high differentiation (P0.05).However,it was not related to any other clinico-pathological characteristic,such as age,axillary lymph node metastasis,tumor size and histology.Conclusion:High expression of Ki67,C-erbB-2 and HIF-1αmay play important roles in down-regulation of ER and therefore the development of primary endocrine therapy resistance.
What problem does this paper attempt to address?